Jump to content

PubMed RSS Feed - -Subtype-Specific Off-Label Treatment of Rosacea


rss

Recommended Posts

Case Rep Dermatol. 2021 Feb 16;13(1):121-128. doi: 10.1159/000511984. eCollection 2021 Jan-Apr.

ABSTRACT

We present 2 cases of rosacea that were successfully managed with off-label treatment. The first is a case of painful, exuding papulopustular lesions of the nose treated with rifaximin, and the other is a case of severe, debilitating and painful flushing treated with sumatriptan. The cases support previous notions that gastrointestinal comorbidities may be related to papulopustular lesions and that flushing may be related to neurogenic inflammation and migraine. The cases also imply that a new approach to rosacea management, based on endotypes and comorbidities, may be warranted.

"Interestingly, infusion of CGRP in patients with migraine induces flushing and can trigger migraine attacks. The anti-migraine drug sumatriptan has been found to block release of CGRP, which may explain the effect in the presented case."

PMID:33790755 | PMC:PMC7989675 | DOI:10.1159/000511984 

{url} = URL to article • Full Text

Sumatriptan has been added to the list of prescription treatments for flushing avoidance

 

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...